vs
Side-by-side financial comparison of INSPERITY, INC. (NSP) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
INSPERITY, INC. is the larger business by last-quarter revenue ($1.7B vs $1.1B, roughly 1.5× PERRIGO Co plc). On growth, INSPERITY, INC. posted the faster year-over-year revenue change (3.4% vs -2.5%). INSPERITY, INC. produced more free cash flow last quarter ($246.0M vs $148.6M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -3.8%).
Insperity, Inc., previously known as Administaff, Inc., is a professional employer organization (PEO) headquartered in Kingwood, an area of Houston, Texas, USA. Insperity provides human resources and administrative services to small and medium-sized businesses. Since 2004, the company has been title sponsor of a professional golf tournament on the Champions Tour, previously known as the Administaff Small Business Classic.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
NSP vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $1.1B |
| Net Profit | — | $-1.4B |
| Gross Margin | 10.3% | 32.6% |
| Operating Margin | -2.8% | -116.0% |
| Net Margin | — | -127.8% |
| Revenue YoY | 3.4% | -2.5% |
| Net Profit YoY | — | -3093.9% |
| EPS (diluted) | $-0.87 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.7B | $1.1B | ||
| Q3 25 | $1.6B | $1.0B | ||
| Q2 25 | $1.7B | $1.1B | ||
| Q1 25 | $1.9B | $1.0B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.6B | $1.1B | ||
| Q2 24 | $1.6B | $1.1B | ||
| Q1 24 | $1.8B | $1.1B |
| Q4 25 | — | $-1.4B | ||
| Q3 25 | $-20.0M | $7.5M | ||
| Q2 25 | $-5.0M | $-8.4M | ||
| Q1 25 | $51.0M | $-6.4M | ||
| Q4 24 | — | $-44.4M | ||
| Q3 24 | $3.0M | $-21.0M | ||
| Q2 24 | $18.0M | $-108.4M | ||
| Q1 24 | $79.0M | $2.0M |
| Q4 25 | 10.3% | 32.6% | ||
| Q3 25 | 12.0% | 36.1% | ||
| Q2 25 | 13.4% | 34.4% | ||
| Q1 25 | 16.6% | 37.6% | ||
| Q4 24 | 13.5% | 33.9% | ||
| Q3 24 | 14.7% | 37.2% | ||
| Q2 24 | 16.2% | 37.0% | ||
| Q1 24 | 19.1% | 33.1% |
| Q4 25 | -2.8% | -116.0% | ||
| Q3 25 | -1.5% | 7.0% | ||
| Q2 25 | -0.4% | 4.3% | ||
| Q1 25 | 3.7% | 4.5% | ||
| Q4 24 | -0.9% | 10.0% | ||
| Q3 24 | 0.1% | 7.4% | ||
| Q2 24 | 1.4% | -2.5% | ||
| Q1 24 | 6.0% | -5.1% |
| Q4 25 | — | -127.8% | ||
| Q3 25 | -1.2% | 0.7% | ||
| Q2 25 | -0.3% | -0.8% | ||
| Q1 25 | 2.7% | -0.6% | ||
| Q4 24 | — | -3.9% | ||
| Q3 24 | 0.2% | -1.9% | ||
| Q2 24 | 1.1% | -10.2% | ||
| Q1 24 | 4.4% | 0.2% |
| Q4 25 | $-0.87 | $-10.23 | ||
| Q3 25 | $-0.53 | $0.05 | ||
| Q2 25 | $-0.14 | $-0.06 | ||
| Q1 25 | $1.35 | $-0.05 | ||
| Q4 24 | $-0.21 | $-0.32 | ||
| Q3 24 | $0.07 | $-0.15 | ||
| Q2 24 | $0.48 | $-0.79 | ||
| Q1 24 | $2.08 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $682.0M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $46.0M | $2.9B |
| Total Assets | $2.2B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $682.0M | — | ||
| Q3 25 | $521.0M | $432.1M | ||
| Q2 25 | $511.0M | $454.2M | ||
| Q1 25 | $684.0M | $409.9M | ||
| Q4 24 | $1.2B | $558.8M | ||
| Q3 24 | $596.0M | $1.5B | ||
| Q2 24 | $850.0M | $542.8M | ||
| Q1 24 | $801.0M | $658.5M |
| Q4 25 | $46.0M | $2.9B | ||
| Q3 25 | $87.0M | $4.4B | ||
| Q2 25 | $112.0M | $4.5B | ||
| Q1 25 | $119.0M | $4.4B | ||
| Q4 24 | $97.0M | $4.3B | ||
| Q3 24 | $125.0M | $4.6B | ||
| Q2 24 | $142.0M | $4.5B | ||
| Q1 24 | $140.0M | $4.7B |
| Q4 25 | $2.2B | $8.5B | ||
| Q3 25 | $2.0B | $10.1B | ||
| Q2 25 | $2.0B | $10.1B | ||
| Q1 25 | $2.1B | $9.8B | ||
| Q4 24 | $2.6B | $9.6B | ||
| Q3 24 | $1.9B | $11.2B | ||
| Q2 24 | $2.1B | $10.4B | ||
| Q1 24 | $2.1B | $10.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $255.0M | $175.4M |
| Free Cash FlowOCF − Capex | $246.0M | $148.6M |
| FCF MarginFCF / Revenue | 14.7% | 13.4% |
| Capex IntensityCapex / Revenue | 0.5% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-309.0M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $255.0M | $175.4M | ||
| Q3 25 | $-11.0M | $51.7M | ||
| Q2 25 | $-79.0M | $75.9M | ||
| Q1 25 | $-443.0M | $-64.5M | ||
| Q4 24 | $619.0M | $312.6M | ||
| Q3 24 | $-150.0M | $42.2M | ||
| Q2 24 | $20.0M | $9.5M | ||
| Q1 24 | $31.0M | $-1.4M |
| Q4 25 | $246.0M | $148.6M | ||
| Q3 25 | $-20.0M | $29.8M | ||
| Q2 25 | $-86.0M | $56.7M | ||
| Q1 25 | $-449.0M | $-90.0M | ||
| Q4 24 | $606.0M | $274.9M | ||
| Q3 24 | $-164.0M | $15.1M | ||
| Q2 24 | $14.0M | $-18.9M | ||
| Q1 24 | $26.0M | $-26.5M |
| Q4 25 | 14.7% | 13.4% | ||
| Q3 25 | -1.2% | 2.9% | ||
| Q2 25 | -5.2% | 5.4% | ||
| Q1 25 | -24.1% | -8.6% | ||
| Q4 24 | 37.6% | 24.2% | ||
| Q3 24 | -10.5% | 1.4% | ||
| Q2 24 | 0.9% | -1.8% | ||
| Q1 24 | 1.4% | -2.4% |
| Q4 25 | 0.5% | 2.4% | ||
| Q3 25 | 0.6% | 2.1% | ||
| Q2 25 | 0.4% | 1.8% | ||
| Q1 25 | 0.3% | 2.4% | ||
| Q4 24 | 0.8% | 3.3% | ||
| Q3 24 | 0.9% | 2.5% | ||
| Q2 24 | 0.4% | 2.7% | ||
| Q1 24 | 0.3% | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | -8.69× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -50.00× | — | ||
| Q2 24 | 1.11× | — | ||
| Q1 24 | 0.39× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NSP
| Northeast | $455.0M | 27% |
| West | $339.0M | 20% |
| Southwest | $317.0M | 19% |
| Central | $299.0M | 18% |
| Southeast | $241.0M | 14% |
| Other Revenues | $17.0M | 1% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
